BDO Wealth Advisors’s Sarepta Therapeutics SRPT Stock Holding History

BDO Wealth Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$80.2K	Hold	700	–	–	0.01%	362
2023 Q1	$96.5K	Hold	700	–	–	0.01%	332
2022 Q4	$90.7K	Hold	700	–	–	0.01%	343
2022 Q3	$77K	Hold	700	–	–	0.01%	354
2022 Q2	$52K	Hold	700	–	–	0.01%	403
2022 Q1	$55K	Sell	700 -129	-16%	-$9.88K	0.01%	416
2021 Q4	$75K	Sell	829 -65	-7%	-$5.56K	0.01%	385
2021 Q3	$83K	Sell	894 -30	-3%	-$2.31K	0.01%	379
2021 Q2	$72K	Sell	924 -20	-2%	-$1.52K	0.01%	413
2021 Q1	$70K	Sell	944 -10	-1%	-$923	0.01%	404
2020 Q4	$163K	Hold	954	–	–	0.02%	249
2020 Q3	$134K	Hold	954	–	–	0.02%	248
2020 Q2	$153K	Hold	954	–	–	0.03%	243
2020 Q1	$93K	Hold	954	–	–	0.02%	277
2019 Q4	$123K	Hold	954	–	–	0.03%	230
2019 Q3	$72K	Hold	954	–	–	0.02%	279
2019 Q2	$145K	Hold	954	–	–	0.04%	220
2019 Q1	$114K	Hold	954	–	–	0.03%	215
2018 Q4	$104K	Hold	954	–	–	0.04%	200
2018 Q3	$154K	Hold	954	–	–	0.05%	177
2018 Q2	$126K	Hold	954	–	–	0.04%	199
2018 Q1	$71K	Buy	+954	New	+$63.6K	0.03%	216
2017 Q3	–	Sell	-975	Closed	-$33K	–	532
2017 Q2	$33K	Buy	+975	New	+$31.7K	0.01%	261

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BDO Wealth Advisors's SRPT Position: Q2 2023 in Review

BDO Wealth Advisors held its Sarepta Therapeutics (SRPT) position steady in Q2 2023 at 700 shares worth $80.2K. The position accounts for 0.01% of the portfolio, ranked #362.

BDO Wealth Advisors first reported a position in SRPT in Q2 2017 and has held it in 23 quarters since. The position peaked at $163K in Q4 2020. 404 funds tracked by Wall St. Rank hold SRPT as of Q2 2023.

BDO Wealth Advisors held 700 shares of Sarepta Therapeutics worth $80.2K as of Q2 2023.
BDO Wealth Advisors left its Sarepta Therapeutics share count unchanged in Q2 2023.
Sarepta Therapeutics made up 0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #362 holding.
BDO Wealth Advisors first reported a position in Sarepta Therapeutics in Q2 2017 and has held it in 23 quarters since.
BDO Wealth Advisors's Sarepta Therapeutics position peaked at $163K in Q4 2020.
404 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.